-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Tonix Pharmaceuticals Holding Corp. quarterly/annual Cost of Revenue history and growth rate from Q3 2023 to Q2 2025.
- Tonix Pharmaceuticals Holding Corp. Cost of Revenue for the quarter ending June 30, 2025 was $3.27M, a 2.82% decline year-over-year.
- Tonix Pharmaceuticals Holding Corp. Cost of Revenue for the twelve months ending June 30, 2025 was $6.95M.
- Tonix Pharmaceuticals Holding Corp. annual Cost of Revenue for 2024 was $7.77M, a 63.8% increase from 2023.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)